Viswanath Manickam

Viswanath Manickam has extensive experience in the pharmaceutical industry, specifically in the field of fermentation and API manufacturing. Viswanath currently holds the position of Head of API Fermentation R&D and PP at Biological E. Limited since July 2020. Prior to that, they served as the Head of Fermentation at AUROBINDO PHARMA LIMITED from April 2019 to July 2020. Before that, they were the Head of R&D Fermentation at Concord Biotech Limited from September 2017 to April 2019. Viswanath also served as the Vice President of BioPharma at Wanbury Ltd from June 2013 to September 2017, and as the Head of Biotechnolgy, R&D & New Businesses at Thirumalai Ltd from August 2006 to June 2013.

Their earlier roles include serving as DGM of API Manufacturing at Allembic Chemicals from December 2005 to July 2006, and at Glenmark Pharmaceuticals from February 2004 to December 2005. Viswanath also held the position of Senior Manager of Fermentation at RPG Life Sciences Ltd. from December 2000 to February 2004. Additionally, they worked as a Research Associate at Ranbaxy from 1995 to 2000, and as a Research Associate of Fermentation at Torrent Pharmaceuticals Ltd from February 1991 to February 1995, where they were part of the Penicillin Technology transfer team from Pan Labs Taiwan and scaled up various technologies.

Viswanath Manickam has a Bachelor of Science (BSc) degree in an unspecified field of study from The Maharaja Sayajirao University of Baroda. Viswanath also has a Master of Science (MSc) degree in microbiology from M S University. Additionally, they have a certification called Paul Harris Foundation Certificate, but the details of the institution and the year obtained are not provided.